Login / Signup

Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome.

Antonella PaladiniGuistino VarassiGiuseppe BentivegnaSandro CarlettiAlba PiroliStefano Coaccioli
Published in: Pain research and treatment (2017)
This observational study provides evidence, albeit preliminary, for the efficacy and safety of um-PEA (Normast) as part of a multimodal therapeutic regimen in the treatment of pain-resistant patients suffering from failed back surgery syndrome.
Keyphrases
  • minimally invasive
  • end stage renal disease
  • coronary artery bypass
  • pain management
  • chronic kidney disease
  • ejection fraction
  • case report
  • prognostic factors
  • spinal cord injury
  • acute coronary syndrome